The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)

US National Institutes of Health (NIH) grant open #PAR-26-134

Response due Nov 22, 2028 · 00:00 UTC

Summary

The National Institutes of Health (NIH) is soliciting research project applications under the Metastasis Research Network (MetNet) program via a U01 cooperative agreement mechanism. The opportunity is specifically designated as "Clinical Trial Not Allowed," meaning proposed projects must be non-clinical in nature. The program aims to support collaborative metastasis research across the network. Applications are open from February 2026 through November 2028, indicating a multi-cycle funding opportunity.

What they want

Technical requirements

Clinical trials are not allowed under this funding opportunity
Must align with Metastasis Research Network (MetNet) program objectives
U01 cooperative agreement mechanism required

How they evaluate

Submission: Grants.gov federal grants portal (PAR-26-134)

Risks & flags

No dollar value or award range stated — budget expectations are unclear
Very broad multi-year open window (Feb 2026 – Nov 2028) with no per-cycle submission deadlines visible in the excerpt, making competitive landscape difficult to assess
Limited scope detail in the synopsis — full Program Announcement (PAR-26-134) should be reviewed for eligibility restrictions that could narrow the applicant pool

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541711

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

The Metastasis Research Network (MetNet): …

Due Nov 22

Onboard ↗